RxDoctor Payments Data

Kimberly Johnson, NP

Nurse Practitioner · Perry, GANPI 1043526460

Payments from drug & device makers

$2,030in general payments, 2019–2025

Across 113 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$315
  • Novo Nordisk$309
  • AbbVie$259
  • Amgen$144
  • Novartis$137
  • Corcept Therapeutics$117
  • plus $750 from 23 others

What the payments were for

  • Food & beverage$2,030100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,030 in reported general payments places this provider in the 80th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Medicare billing

Part B allowed, 2024
$75,909
Medicare patients
206
Services billed
2,092

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide34$36,812
OzempicSemaglutide26$29,014
EliquisApixaban36$23,218
FarxigaDapagliflozin Propanediol15$9,090
JanuviaSitagliptin Phosphate12$6,525
Allopurinol21$1,959
Venlafaxine Hcl ErVenlafaxine Hcl12$1,404
Duloxetine Hcl18$1,139
Risperidone OdtRisperidone17$1,126
Atorvastatin Calcium78$590
Famotidine30$558
Telmisartan13$520
Gabapentin38$482
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide20$472
Rosuvastatin Calcium48$446

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$98$36,81234 claims
Novo NordiskOzempic$309$29,01426 claims
PfizerEliquis$315$23,21836 claims
AstraZenecaFarxiga$18$9,09015 claims
MerckJanuvia$18$6,52512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,328 nurse practitioner providers in Georgia.

Other nurse practitioner in Perry

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →